Molecular Diagnostics

Genomic Biomarkers Assess Treatment Prognosis in Blood Cancers
The biomarker gene, splicing factor 3B subunit 1, is believed to play a critical role in the prognosis of patients with myelodysplastic syndromes, a group of hematological cancers in which bone marrow does not produce enough healthy blood cells. More...04 Aug 2014





In Other News
Genetic Test Improves Prognosis for Esophageal Cancer
Whole-Exome Sequencing Identifies Mitochondrial Disorder Biomarkers
Blood Test Developed to Indicate Breast Cancer Risk
Gene Type Associated with Higher Risk of Celiac Disease
New Blood Test Identifies Sudden Cardiac Death Risk
New Adiponectin Test Kit Gains CE Approval
Genotyping Performed by FRET-PCR Without DNA Extraction
Liver Values Elevated in Overweight Children with Gene Mutation
Simple Urine Test Diagnoses Bladder Cancer Early
MicroRNA Could Help Diagnose Mental Disorders
Mutations in the Apolipoprotein C3 Gene Lower Triglyceride Levels and Reduce Heart Disease Risk
High-Risk Female Groups Screened for Fabry Disease
Molecular Makeup Uncovered in New Form of Cancer
Prostate Cancer Biomarkers Identified in Seminal Fluid
Four New Genes Added to Inherited Breast Cancer Risk List
New Test Improves Reliability of Melanoma Diagnosis
DNA Blood Test Evaluated for Colorectal Cancer Detection
New Genetic Sequencing Methods Means Accurate Embryo Screening
New Software Tool Rapidly Finds Links Between Mutations and Disease in Families
Exome Sequencing Covers Specific Gene Sets Ineffectually
Microarray Analysis of Gene Expression Signatures in Blood Samples Provides Biomarker for Higher Cardiovascular Death Risk
New Multigene Test Improves Assessment of Hereditary Cancers
Many Healthy Adults Infected with Human Papilloma Viruses
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.